Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System
Annals of Pharmacotherapy · 2024-12 · 58 (12) · 1161-1169
DOI: 10.1177/10600280241243071 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Pharmacotherapy, online erschienen am 03.04.2024. Verfasst von Elizabeth M Foster und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh Medical Center - Presbyterian Hospital, Department of Pharmacy, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Diltiazem, Heart Failure, Stroke Volume, Decision Support Systems, Clinical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Despite atrial fibrillation guideline recommendations, many patients with heart failure with reduced ejection fraction (EF) continue to receive IV diltiazem for acute rate control.
Objective
Our institution recently implemented a clinical decision support system (CDSS)-based tool that recommends against the use of diltiazem in patients with an EF ≤ 40%. The objective of this study was to evaluate outcomes of adherence to the aforementioned CDSS-based tool.
Methods
This multi-hospital, retrospective study assessed patients who triggered the CDSS alert and compared those who did and did not discontinue diltiazem. The primary outcome was the occurrence of clinical deterioration. The primary endpoint was compared utilizing a Fisher’s Exact Test, and a multivariate logistic regression model was developed to confirm the results of the primary analysis.
Results
A total of 246 patients were included in this study with 146 patients in the nonadherent group (received diltiazem) and 100 patients in the adherent group (did not receive diltiazem). There was a higher proportion of patients experiencing clinical deterioration in the alert nonadherence group (33% vs 21%, P = 0.044), including increased utilization of inotropes and vasopressors, and higher rate of transfer to ICU. Conclusion and Relevance: In patients with heart failure with reduced EF, diltiazem use after nonadherence to a CDSS alert resulted in an increased risk of clinical deterioration. This study highlights the need for improved provider adherence to diltiazem clinical decision support systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Pittsburgh Medical Center - Presbyterian Hospital, Department of Pharmacy, Pittsburgh, PA, USA.
- University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- University of Pittsburgh Medical Center, Heart and Vascular Institute, Pittsburgh, PA, USA.
- University of Pittsburgh Medical Center, Department of Emergency Medicine, Pittsburgh, PA, USA.
ORCID-Profile: Elizabeth M Foster
Zitieren
APA
Foster, E. M., Coons, J. C., Puccio, E. A., Sullinger, D., Ibrahim, R., Ibrahim, J., Hickey, G. W., Horn, E., Mosesso, V., & Rivosecchi, R. M. (2024). Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System. Annals of Pharmacotherapy, 58(12), 1161-1169. https://doi.org/10.1177/10600280241243071
Vancouver
Foster EM, Coons JC, Puccio EA, Sullinger D, Ibrahim R, Ibrahim J, et al. Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System. Annals of Pharmacotherapy. 2024;58(12):1161-1169. doi:10.1177/10600280241243071
BibTeX
@article{Foster2024,
author = {Foster, Elizabeth M and Coons, James C and Puccio, Elena A and Sullinger, Danine and Ibrahim, Rachel and Ibrahim, Joseph and Hickey, Gavin W and Horn, Edward and Mosesso, Vincent and Rivosecchi, Ryan M},
title = {Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System},
journal = {Annals of Pharmacotherapy},
year = {2024},
volume = {58},
number = {12},
pages = {1161--1169},
doi = {10.1177/10600280241243071}
}
EUVIMED